Clin2
NCT07750340Possibly a fitNot yet recruiting

Breast cancer types and bone scan findings

Breast Cancer

Part of Cancer, Skin clinical trials.

This study looks at how different types of breast cancer (based on hormone and protein markers) relate to where cancer spreads to the bones. It uses bone scans to find patterns of bone metastases, which may help doctors better predict and monitor the disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You must have been diagnosed with breast cancer (any type).
  • You must be between 18 and 80 years old.
  • Your doctor must have tested your breast cancer for estrogen and progesterone receptors and HER2 status.
  • You must be having a bone scan to check for cancer spread to your bones.
  • You must not have any other cancer besides breast cancer.
  • You must not be pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06833502Recruiting· Phase 2
Screening for breast cancer spread after chemo and surgery

This trial aims to find out if doing special scans to check for breast cancer spread to organs (not just lymph nodes) is helpful in certain patients. The study looks at people with breast cancer that had already spread to lymph nodes and did not completely go away with chemotherapy and surgery.

Tampa, Florida
NCT07687225Not yet recruiting
Surgery versus no surgery for breast cancer spread to bones only

This trial compares having surgery to remove the breast tumor versus not having surgery in women whose breast cancer has spread only to their bones. The goal is to see which approach helps you live longer or better.

NCT02732171Recruiting
Blood and bone marrow tests to track breast cancer return

This trial checks whether specific “surveillance” markers (measured from blood and bone marrow) can help predict if breast cancer comes back after standard treatments. It may help doctors monitor you more accurately and earlier if recurrence risk is high.

Philadelphia, Pennsylvania
NCT07503717Recruiting
Brain scan surveillance in HER2-positive metastatic breast cancer

This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.

Beaumont
NCT06723132Not yet recruiting
Breast cancer brain metastasis survival study

This study looks at what factors affect how long people with breast cancer that has spread to the brain live. It uses past medical records to find patterns that may help plan better care.

NCT04170634Recruiting
CT scan study to assess bone strength in certain cancers

This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.

Angers

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.